Alaunos Therapeutics, Inc. (TCRT)

Alaunos Therapeutics Revenue

Alaunos Therapeutics had revenue of $3.00K in the twelve months ending March 31, 2026, down -70.00% year-over-year. In the year 2025, Alaunos Therapeutics had annual revenue of $5.00K, down -50.00%.

• Revenue (ttm): $3.00K
• Revenue Growth: -70.00%
• P/S Ratio: 1,938.28
• Revenue / Employee: $3,000
• Employees: 1
• Market Cap: 5.76M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.00K	-5.00K	-50.00%
Dec 31, 2024	10.00K	5.00K	100.00%
Dec 31, 2023	5.00K	-2.92M	-99.83%
Dec 31, 2022	2.92M	2.52M	634.17%
Dec 31, 2021	398.00K	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	146.00K	-6.24M	-97.71%
Dec 31, 2017	6.39M	-472.00K	-6.88%
Dec 31, 2016	6.86M	2.53M	58.38%
Dec 31, 2015	4.33M	2.96M	215.51%
Dec 31, 2014	1.37M	573.00K	71.63%
Dec 31, 2013	800.00K	-	-
Dec 31, 2012	800.00K	133.00K	19.94%
Dec 31, 2011	667.00K	-	-
Dec 31, 2010	-	-	-
Dec 31, 2009	-	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	-	-	-
Dec 31, 2006	-	-	-

Data Source: Fiscal.ai Last updated: May 15, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error